Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-000835
Filing Date
2022-02-03
Accepted
2022-02-03 16:57:18
Documents
1
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5161
  Complete submission text file 0001179110-22-000835.txt   6627
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Almstead Neil Gregory (Reporting) CIK: 0001578850 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 22589439